Limited Competition: Genomic Risk and Resilience in 22q11 Deletion Syndrome: A Window into the Genetic Architecture of Mental Disorders (Collaborative R01)

Post Date

August 2nd 2012

Application Due Date

November 13th 2012

Funding Opportunity Number

RFA-MH-13-120

CFDA Number(s)

93.242

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

Other

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Funding

• Estimated Total Funding:

  $3000000

• Award Range:

  $None - $None

Grant Description

This limited competition Funding Opportunity Announcement (FOA), issued by the National Institute of Mental Health (NIMH), invites applications for collaborative R01 awards from the International Consortium for 22q Del Syndrome Research for the genomic analysis of existing samples from Consortium recruited research subjects. The goal of this FOA is to use 22q DS as a model to dissect the overall genetic architecture and to identify specific genomic risk and resilience factors of brain behavioral and neuropsychiatric phenotypes associated with the syndrome.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-13-120.html